Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.

[1]  T. Högberg.  Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[2]  H. Putter,et al.  Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomized PORTEC-2 trial , 2008 .

[3]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[4]  A. Usubutun,et al.  Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery , 2007, International Journal of Gynecologic Cancer.

[5]  P. Grigsby,et al.  External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. , 2007, Gynecologic oncology.

[6]  J. Cooper,et al.  Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. , 2006, Gynecologic oncology.

[7]  P. Zola,et al.  Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial , 2006, British Journal of Cancer.

[8]  I. Petersen,et al.  Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer. , 2005, International journal of radiation oncology, biology, physics.

[9]  S. Jolly,et al.  Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. , 2005, Gynecologic oncology.

[10]  E. Venkatraman,et al.  Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. , 2005, International journal of radiation oncology, biology, physics.

[11]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .

[12]  Keith D. Jones,et al.  High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone. , 2003, Gynecologic oncology.

[13]  T. Mate,et al.  Adjuvant High Dose Rate Vaginal Brachytherapy as Treatment of Stage I and II Endometrial Carcinoma , 2002, Obstetrics and gynecology.

[14]  J. Fanning.  Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. , 2001, Gynecologic oncology.

[15]  J. Nicklin,et al.  Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy. , 2000, Gynecologic oncology.

[16]  P. Koper,et al.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.

[17]  J. Anderson,et al.  High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer. , 2000, International journal of radiation oncology, biology, physics.

[18]  V. Abeler,et al.  Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS , 1980, Obstetrics and gynecology.

[19]  Nobuyuki Susumu,et al.  Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. , 2008, Gynecologic oncology.

[20]  M. Chadha.  Gynecologic brachytherapy-II: Intravaginal brachytherapy for carcinoma of the endometrium. , 2002, Seminars in radiation oncology.